Prognostic and predictive value of YTHDF1 and YTHDF2 and their correlation with tumor-infiltrating immune cells in non-small cell carcinoma.

Front Oncol · 2022 · PMC9720116 · PMID 36479088

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In the squamous cell carcinoma group not receiving PD-1/PD-L1 inhibitor treatment, the immunohistochemical expression of YTHDF1 or YTHDF2 showed a trend toward better overall survival but was not statistically significant ( p = 0.062, Figure 4B and p = 0.097, Figure 4D , respectively).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.